Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DROP-LCMS for wastewater surveillance of viral disease.

Lab on a chip·2026
Same author

Chemical Exposure Assessment in Traditional Korean Pottery Workplaces.

Safety and health at work·2026
Same author

A combined digital microfluidic test for assessing infection and immunity status for viral disease in saliva.

Lab on a chip·2025
Same author

A compartmentalization-free microfluidic digital assay for detecting picogram levels of protein analytes.

Lab on a chip·2025
Same author

A digital microfluidic approach to increasing sample volume and reducing bead numbers in single molecule array assays.

Lab on a chip·2025
Same author

Distinct Proteomic Brain States Underlying Long-Term Memory Formation in Aversive Operant Conditioning.

Journal of proteome research·2024

Related Experiment Video

Updated: Jun 7, 2025

A Versatile Automated Platform for Micro-scale Cell Stimulation Experiments
12:21

A Versatile Automated Platform for Micro-scale Cell Stimulation Experiments

Published on: August 6, 2013

10.5K

A multimodal digital microfluidic testing platform for antibody-producing cell lines.

Jeremy T Lant1,2, Jurgen Frasheri2,3, Taehong Kwon4

  • 1Department of Chemistry, University of Toronto, Toronto, Ontario, Canada. aaron.wheeler@utoronto.ca.

Lab on a Chip
|November 20, 2024
PubMed
Summary
This summary is machine-generated.

Digital microfluidics offers a novel platform for optimizing monoclonal antibody (mAb) production. This miniaturized system automates cell line testing, reducing development costs and time-to-market for therapeutic antibodies.

More Related Videos

Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay
08:22

Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay

Published on: February 23, 2020

9.5K
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.2K

Related Experiment Videos

Last Updated: Jun 7, 2025

A Versatile Automated Platform for Micro-scale Cell Stimulation Experiments
12:21

A Versatile Automated Platform for Micro-scale Cell Stimulation Experiments

Published on: August 6, 2013

10.5K
Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay
08:22

Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay

Published on: February 23, 2020

9.5K
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.2K

Area of Science:

  • Biotechnology
  • Chemical Engineering
  • Bioprocess Engineering

Background:

  • Monoclonal antibodies (mAbs) are crucial therapeutics approved for various diseases.
  • Mammalian cell lines are the primary production system for therapeutic mAbs.
  • Optimizing mAb production is essential for reducing therapeutic development costs.

Purpose of the Study:

  • To present a novel digital microfluidics platform for cell line optimization in mAb production.
  • To demonstrate the utility of miniaturized, automated assays for mAb development.

Main Methods:

  • Development of a digital microfluidics platform for handling small droplet volumes (6-8 μL).
  • Implementation of semi-automated assays for cell viability, media pH, and antibody production.
  • Integration of cell growth and productivity metrics within the microfluidic system.

Main Results:

  • The platform enables simultaneous testing of multiple parameters using minimal sample volumes.
  • Provides a bridge between cell growth and productivity data for informed optimization.
  • Reduces the volume of culture required for daily testing and analysis.

Conclusions:

  • The digital microfluidics platform offers a valuable tool for efficient cell line optimization in mAb production.
  • This technology has the potential to significantly decrease the time-to-market and development costs for antibody therapeutics.
  • Future iterations may further enhance automation and expand assay capabilities for biopharmaceutical development.